The genetic basis of retinoblastoma was long believed to be predominantly limited to biallelic loss of RB1. Other non-RB1 genes have previously been identified [7,8,17] and their clinical relevance sparingly elucidated. This evidence concerns the gene RB1 and retinoblastoma.